Abstract:Objective To explore the predictive value of serum angiopoietin-2 (Ang2), unconjugated estriol (uE3), and pregnancy-associated plasma protein-A (PAPP-A) for placental abruption in patients with preeclampsia.Methods A retrospective study was conducted on 84 pregnant women with preeclampsia treated in the Northwest Women's and Children's Hospital from December 2021 to June 2023. Additionally, 84 pregnant women with normal prenatal examination results were selected as the control group. Those with preeclampsia were further divided into the placental abruption group (23 cases) and the non-abruption group (61 cases). Serum levels of Ang2, uE3, and PAPP-A were measured, and these indicators and clinical characteristics of patients were compared among the groups. Multivariable logistic regression was used to analyze factors influencing placental abruption in patients with preeclampsia, and the diagnostic value of Ang2, uE3, PAPP-A and their combination for placental abruption was assessed using receiver operating characteristic (ROC) curves.Results SBP, DBP, and levels of uric acid, albumin, and PAPP-A were significantly higher in the study group compared to the control group (P < 0.05), whereas Ang2 and uE3 levels were significantly lower in the study group (P < 0.05). The placental abruption group had higher SBP and levels of uric acid and PAPP-A, but lower levels of Ang2 and uE3, compared to the non-abruption group (P < 0.05). The multivariable logistic regression analysis demonstrated that elevated SBP [O^R = 1.232 (95% CI: 1.165, 1.302) ], increased levels of uric acid [O^R = 1.010 (95% CI: 1.006, 1.014) ], decreased levels of Ang2 [O^R = 0.593 (95% CI: 0.423, 0.830) ], decreased levels of uE3 [O^R = 0.001 (95% CI: 0.000, 0.006) ], and increased levels of PAPP-A [O^R = 0.998 (95% CI: 0.996, 1.000) ] were all independent risk factors associated with the occurrence of placental abruption in patients with preeclampsia (P < 0.05). ROC curve analysis showed that the sensitivities of Ang2, uE3, and PAPP-A for predicting placental abruption in patients with preeclampsia were 82.6%, 82.6%, and 73.9%, with the specificities being 59.0%, 93.4%, and 78.7%, and areas under the curves (AUCs) being 0.730, 0.893, and 0.768. The combination of these indicators yielded a sensitivity of 91.3%, with a specificity of 91.8%, and an AUC of 0.919.Conclusion Patients with preeclampsia complicated by placental abruption exhibit abnormally low serum levels of Ang2 and uE3, and abnormally high levels of PAPP-A. The combination of these markers demonstrates high predictive efficacy for placental abruption and holds significant clinical utility.